TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

CUSIP: 88338N206

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
11,549,491
Total 13F shares
10,800
Share change
+800
Total reported value
$4,104
Price per share
$0.38
Number of holders
2
Value change
+$304
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 88338N206?
CUSIP 88338N206 identifies TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) as of Q1 2022

As of 31 Mar 2022, TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,800 shares. The largest 2 holders included SILVERLAKE WEALTH MANAGEMENT LLC and Baron Financial Group, LLC. This page lists 2 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.